Monthly Archives: October 2014

APVS Receives Key Stakeholder Invitation from the Nigerian Ministry of Health

The Nigerian Government recently completed a national TB prevalence survey. The survey indicated that the prevalence rate of TB was three times greater than originally estimated. Prevalence refers to the number of cases of TB in a population (usually stated … Continue reading

Posted in Corporate, Healthcare, TB

FIND and APVS Launch TBDx™ Feasibility Evaluation in Peru

The mission of the Foundation for Innovative New Diagnostics (FIND) is to assist in the development and deployment of accurate and affordable diagnostic tests for poverty-related diseases in developing countries. In March, FIND and APVS entered into a collaboration agreement … Continue reading

Posted in Corporate, Healthcare, TB | Tagged , , , , , , , , , , , , , , , , , , ,

TBDx™ Selected for Workshop Evaluation in India

Dr. Soumya Swaminathan, Director of the National Institute for Research in Tuberculosis (NIRT), has extended a formal invitation (NIRT Invite) to attend a December 8th – 12th workshop in Chennai, India. The stated purpose of the conference is to conduct … Continue reading

Posted in Corporate, Healthcare, TB | Tagged , , , , , , , , , , , , , | 1 Comment

2014 – 3rd Quarter Business Update

“Success is not final; failure is not fatal. It is the courage to continue that counts.”     Winston Churchill Let’s get the lone negative out-of-the-way – the investment catalyst that we anticipated would occur during the 3rd quarter did not occur.  … Continue reading

Posted in Corporate, Healthcare, TB | Tagged , , , , , , , , , , , , , , , , ,